1. Abstracts from the 4th ImmunoTherapy of Cancer Conference: Prague, Czech Republic. 20–22 March 2017. (20th March 2017) Authors: Ženka, J.; Caisová, V.; Uher, O.; Nedbalová, P.; Kvardová, K.; Masáková, K.; Krejčová, G.; Paďouková, L.; Jochmanová, I.; Wolf, K. I.; Chmelař, J.; Kopecký, J.; Loumagne, L.; Mestadier, J.; D'agostino, S.; Rohaut, A.; Ruffin, Y.; Croize, V.; Lemaître, O.; Sidhu, S. S. Journal: Journal for immunotherapy of cancer Issue: Volume 5(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts the (serum) chemokine-release profile to a more 'inflammatory' (in culture) going along with improved antileukemic T-cell-reactivity. (March 2019) Authors: Merle, M.; Fischbacher, D.; Liepert, A.; Grabrucker, C.; Kroell, T.; Kremser, A.; Dreyssig, J.; Freudenreich, M.; Schuster, F.; Borkhardt, A.; Kraemer, D.; Koehne, C.; Kolb, H.J.; Schmid, C.; Schmetzer, H.M. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High thermoelectric conversion efficiency of MgAgSb-based material with hot-pressed contacts1. Issue 4 (1st April 2015) Authors: Kraemer, D.; Sui, J.; McEnaney, K.; Zhao, H.; Jie, Q.; Ren, Z. F.; Chen, G. Journal: Energy & environmental science Issue: Volume 8:Issue 4(2015) Page Start: 1299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Modulation of AML-blasts with clinically approved response modifiers to leukemia-derived dendritic cells (DCleu) ex vivo: DC-, T-cell- and cytokine profiles are predictive for antileukemic T-cell reactivity. (March 2019) Authors: Fischer, Z.; Deen, D.; Hirn, A.; Plett, C.; Kugler, C.; Rabe, A.; Liepert, A.; Freudenreich, M.; Kraemer, D.; Schmid, C.; Schmetzer, H.M. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease. (18th May 2020) Authors: Merle, M.; Fischbacher, D.; Liepert, A.; Grabrucker, C.; Kroell, T.; Kremser, A.; Dreyssig, J.; Freudenreich, M.; Schuster, F.; Borkhardt, A.; Kraemer, D.; Koehne, C.-H.; Kolb, H. J.; Schmid, C.; Schmetzer, H. M. Journal: Immunological investigations Issue: Volume 49:Number 4(2020) Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Standard normoxic versus physiological hypoxic culture of AML patients' (pts) whole blood (WB) samples with immune modulatory kits yields comparable proportions of dendritic cells and functional results. (March 2018) Authors: Doraneh gard, F.; Amberger, D.; Weinmann, M.; Boeck, C.; Gunsilius, C.; Kugler, C.; Werner, J.; Kraemer, D.; Rank, A.; Schmid, C.; Schmetzer, H. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗